A novel movement-based therapy is being evaluated in infants who suffered a stroke as newborns or in the womb.
Researchers are investigating the safety and effectiveness of a new gene therapy product that replaces the defective β-sarcoglycan gene.
Clinical use of large-scale genetic screening helped end the diagnostic odyssey for many patients with nonspecific neuromuscular phenotypes.
Genome-wide association study identifies two variants that may yield therapies for children with DMD.
A meta-analysis shows people who have experienced concussion and/or mild traumatic brain injury are more likely to attempt suicide and to have suicidal ideation than people who have not experienced the injuries.
You Might Also Be Interested In
Sign Up for PediatricsOnline
Subscribe to PediatricsOnline, a digital newsletter personalized for the pediatric provider to deliver up-to-date resources, research announcements and more.
We offer comprehensive, family-centered care from renowned experts in pediatric neurology. We participate in clinical and scientific research programs, and our faculty members play prominent roles in national and international neurological organizations.